Our top pick for
Frontline Ltd is an oil & gas midstream business based in the US. Frontline shares (FRO) are listed on the NYSE and all prices are listed in US Dollars. Frontline employs 84 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$8.85|
|52-week range||$5.28 - $9.86|
|50-day moving average||$8.12|
|200-day moving average||$8.01|
|Wall St. target price||$86.96|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.25|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||0.11%|
|1 month (2021-09-16)||11.60%|
|3 months (2021-07-16)||11.60%|
|6 months (2021-04-16)||25.71%|
|1 year (2020-10-16)||32.68%|
|2 years (2019-10-16)||-16.27%|
|3 years (2018-10-16)||31.70%|
|5 years (2016-10-14)||18.32%|
Valuing Frontline stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Frontline's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Frontline's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Frontline shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Frontline's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $222.3 million.
The EBITDA is a measure of a Frontline's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$786.3 million|
|Operating margin TTM||10.63%|
|Gross profit TTM||$679.2 million|
|Return on assets TTM||1.3%|
|Return on equity TTM||3.06%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
There are currently 4.4 million Frontline shares held short by investors – that's known as Frontline's "short interest". This figure is 8.8% up from 4.0 million last month.
There are a few different ways that this level of interest in shorting Frontline shares can be evaluated.
Frontline's "short interest ratio" (SIR) is the quantity of Frontline shares currently shorted divided by the average quantity of Frontline shares traded daily (recently around 1.4 million). Frontline's SIR currently stands at 3.05. In other words for every 100,000 Frontline shares traded daily on the market, roughly 3050 shares are currently held short.
However Frontline's short interest can also be evaluated against the total number of Frontline shares, or, against the total number of tradable Frontline shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Frontline's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Frontline shares in existence, roughly 20 shares are currently held short) or 0.0404% of the tradable shares (for every 100,000 tradable Frontline shares, roughly 40 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Frontline.
Find out more about how you can short Frontline stock.
Dividend payout ratio: 217.39% of net profits
Recently Frontline has paid out, on average, around 217.39% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 24.88% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Frontline shareholders could enjoy a 24.88% return on their shares, in the form of dividend payments. In Frontline's case, that would currently equate to about $0 per share.
Frontline's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Frontline's most recent dividend payout was on 28 September 2020. The latest dividend was paid out to all shareholders who bought their shares by 9 September 2020 (the "ex-dividend date").
Frontline's shares were split on a 1:5 basis on 3 February 2016. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Frontline shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Frontline shares which in turn could have impacted Frontline's share price.
Over the last 12 months, Frontline's shares have ranged in value from as little as $5.28 up to $9.86. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Frontline's is 0.2503. This would suggest that Frontline's shares are less volatile than average (for this exchange).
Frontline Ltd. , a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2020, the company operated a fleet of 68 vessels. It is also involved in the charter, purchase, and sale of vessels. Frontline Ltd. is based in Hamilton, Bermuda.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.